Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Chronic Pulmonary Aspergillosis (CPA) on Health Status and Well-being

NCT06885905 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT06885905
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06885905 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Chronic Pulmonary Aspergillosis (CPA) on Health Status and Well-being
Lead sponsor
Imperial College London
Phase
Observational
Overall status
Recruiting
Start date
November 27, 2024
Completion date
April 23, 2026
Enrollment
100 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

chronic pulmonary aspergillosis